electroCore

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell electroCore and other ETFs, options, and stocks.

About ECOR

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems.

CEO

Daniel S. Goldberger

CEODaniel S. Goldberger

Employees

Employees73

Headquarters

Rockaway, New Jersey

HeadquartersRockaway, New Jersey

Founded

2005

Founded2005

Employees

Employees73

ECOR Key Statistics

Market cap

39.70M

Market cap39.70M

Price-Earnings ratio

-3.24

Price-Earnings ratio-3.24

Dividend yield

—

Dividend yield—

Average volume

236.94K

Average volume236.94K

High today

$5.35

High today$5.35

Low today

$5.35

Low today$5.35

Open price

$5.35

Open price$5.35

Volume

2.71K

Volume2.71K

52 Week high

$19.49

52 Week high$19.49

52 Week low

$4.47

52 Week low$4.47

People also own

Based on the portfolios of people who own ECOR. This list is generated using Robinhood data, and it’s not a recommendation.

electroCore

Why Robinhood?

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. Show more

ECOR Key Statistics

People also own

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems.